iboga

Powerful psychedelic drug ibogaine could help people kick opioid addictions

Somewhere around two million Americans suffer from opioid-related substance use disorder. Treatments like buprenorphine and methadone calm the brain circuits affected by opioids, reducing ...
tci shrm feat image

Seeking mainstream acceptance for psychedelic drugs: Will entrepreneurs ruin it for everyone else?

After spending decades as highly illegal and restricted substances, psilocybin (magic mushrooms), LSD, MDMA, DMT, and other psychedelic drugs are ...
psyy x

Trends that will shape the 2020s: Psychedelics as medicine, diagnostic cell phone apps and AI prediction of disease outbreaks

Clearly, a lot can happen in a decade—but innovation has to start somewhere. Based on what’s breaking through now, here ...
psillow header x microdosing x

Video: Placebo effect or powerful antidepressant? Understanding the science of psychedelic microdosing

Individuals who microdose mushrooms, or those who microdose LSD, claim to experience an elevated mood, increased productivity, and a greater ...
psychonauts

Psychedelics have ‘extraordinarily potent’ anti-inflammatory power. Is there a place for them in mainstream medicine?

Research on psychedelics, which have been profoundly stigmatized, highly restricted, and tragically undeveloped for more than half a century, is ...
gettyimages

Taking psychoactive drugs can mirror near death experiences, study shows

In a fascinating new study, [near-death experience] stories were compared linguistically with anecdotes of drug experience in order to identify a ...
nym microdosing x

Chasing a brain boost through psychedelic microdosing? Scientific support is ‘patchy, lacking’, review says

The practice of taking small, regular doses of psychedelic drugs to enhance mood, creativity, or productivity lacks robust scientific evidence ...
ap x

Inside the quest to find a place in modern medicine for magic mushrooms as a treatment for depression, other mental illnesses

Today, with a net worth of roughly $400 million accrued through various enterprises, [German financier Christian] Angermayer is one of ...
mushrooms x

How the rush to decriminalize magic mushrooms could hurt psychedelic drug research

Welcome to a murky new front in the war to bring psychedelics out of the shadows and into both legal ...
maxresdefault

Explaining hallucinations through math

[Researcher Heinrich Klüver] classified [hallucinogenic patterns he experienced] into four distinct types that he dubbed “form constants”: lattices (including checkerboards, ...